unii-7wvh15jykm

Camsirubicin, also known as GPX-150, MNPR-201, and CNDO1011, is a synthetic non-cardiotoxic analogue of the anthracycline antibiotic doxorubicin with potential antineoplastic activity. Anthracycline analogue GPX-150 intercalates DNA and impedes the activity of topoisomerase II, inducing single and double-stranded breaks in DNA; inhibiting DNA replication and or repair, transcription, and protein synthesis; and activating tumor cell apoptosis.

Camsirubicin is a drug candidate of antineoplastic.